-Newslaundry.com The election season seems to have skipped adivasis in the state that has recorded 19 deaths from starvation since 2017. On New Year’s Eve, Baghiya Birijiya lost her mother Budhni Birijiyan to hunger, cold, and extreme poverty in Latehar, one of India’s poorest districts. The family had so few means that they could not cremate the 80-year-old’s body for two days, until public pressure led the administration to intervene to provide...

-Livemint.com * Out of the 1.8 million people living in the Banswara district in 3.6 lakh households, 78% are tribals * With a 46.1% literacy rate, 91.3% of households earn less than ?5,000 per month Banswara, Rajasthan: When Ramchandar, 52, wakes up in his thatched house every morning in the hilly tribal village of Katumbi in Rajasthan's Banswara district, his first preoccupation is to fetch water from the nearest village at a distance...

-The Hindu Business Line The former PM added that the economic stimulus that NYAY will provide will further help in fiscal discipline India's nearly $3 trillion economy has the fiscal capacity to absorb the expenditure to fund NYAY, the minimum income support scheme promised by Congress Party, without the need for any new taxes on the middle class, former Prime Minister of India, Dr Manmohan Singh, said. NYAY scheme -- announced by Congress...

-Scroll.in It is time for citizens to set an agenda for long-term governance, writes Anirudh Krishna in this excerpt from ‘Re-forming India’. Fixing the cycle of poverty – preventing descents and enabling escapes – is eminently possible. Other middle-income countries have much lower levels of poverty. It requires, however, that things work well in the public realm – that everyone, and not just the few who are assisted currently by social service...

-The Times of India NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows highlighting the “exorbitant” profiteering by pharmaceutical companies and the scope for lowering prices of drugs. While innovative and newer drugs for cancer, hepatitis C and rare diseases are out of reach of many due to their unaffordable prices,...